The Motley Fool · Jul 16, 2021
Why GX Acquisition Stock Soared Today
The SPAC closed its merger with clinical-stage biotech Celularity.
GX
NASDAQ · GXGX
Celularity Inc.
Financial Services · Shell Companies
$10.20
Up+$2.18 (+27.18%)
Updated Oct 6, 2026, 11:22 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.48B
- P/E ratio
- -0.54
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 17.32M
- Avg. volume
- 621.77K
Price performance · GXGX
GXGX price history
1M range · 0 trading sessions · Daily adjusted prices
GXGX does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest GXGX news
The latest Smart Investors Daily articles mentioning GXGX.
Stock researchCompany · Overview
Company
Market Activity
Research & News
GXGX research
Overview
Company profile and research snapshot.
Company profile
GX Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company is not engaged in any business operations and it has not generated any revenue.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 26, 2021 | BTIG | Buy | — |
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
